Denali Therapeutics Inc. DNLI Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s short-term investments?
- Denali Therapeutics Inc. (DNLI) reported short-term investments of $600.06M in Q1 2026.
- How has Denali Therapeutics Inc.'s short-term investments changed year-over-year?
- Denali Therapeutics Inc.'s short-term investments decreased by 21.1% year-over-year, from $760.98M to $600.06M.
- What is the long-term trend for Denali Therapeutics Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s short-term investments has grown at a -7.2% compound annual growth rate (CAGR), from $962.55M to $662.55M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.